Lentiviral TREM2 overexpression
Lentiviral TREM2 overexpression has been studied in 1 paper since 2016: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 16, 2016: “TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice”.
InterventionPreclinical
1 paper studies it3 findingsUpdated
See all 1 papers on lentiviral TREM2 overexpression
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Animals1
What did studies of lentiviral TREM2 overexpression find?
3Studies of lentiviral TREM2 overexpression measured 3 outcomes: clathrin-mediated endocytosis, Alzheimer's disease and spatial cognitive functions.
Clathrin-mediated endocytosis
no changein mouse cells1
1 study
Clathrin-mediated endocytosis
no changein mouse cells1
Lentiviral TREM2 overexpression showed no clear effect on clathrin-mediated endocytosis in microglia from aging APPswe/PS1dE9 mice.
“phagocytic deficit in microglia from aging APPswe/PS1dE9 mice cannot be rescued by TREM2 overexpression.”
Cellsin microglia from aging APPswe/PS1dE9 micemicroglia
Molecular neurobiology
Alzheimer's disease
no changein mice1
1 study
Alzheimer's disease
no changein mice1
Lentiviral TREM2 overexpression showed no clear effect on Alzheimer's disease in aging APPswe/PS1dE9 mice.
“TREM2 overexpression has no beneficial effect on AD-related neuropathology and spatial cognitive functions.”
Animalsin aging APPswe/PS1dE9 micebrain
Molecular neurobiology
Spatial cognitive functions
no changein mice1
1 study
Spatial cognitive functions
no changein mice1
Lentiviral TREM2 overexpression showed no clear effect on spatial cognitive functions in aging APPswe/PS1dE9 mice.
“TREM2 overexpression has no beneficial effect on AD-related neuropathology and spatial cognitive functions.”
Animalsin aging APPswe/PS1dE9 micebrain
Molecular neurobiology